Aceragen, Inc. - 45168K306
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q2 2018
· Q2 2014
Value (USD)
Total reported value ($000)
$17.78M
QoQ value delta ($000)
+$386K
(+2.22%)
Implied price effect (QoQ)
-2.54%
Shares
Total shares
6,288,423
QoQ shares delta
+292,570
(+4.88%)
Total shares held by funds (by quarter)
Shares (left)
Fund holders (right)
Top holders (Q2 2018)
Top 25 only
Full list
Partial Q2 2018 data: 1 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| VANGUARD GROUP INC | 6,128 | 2,113,028 | 0.0% |
| BlackRock Fund Advisors | 4,301 | 1,483,174 | 0.0% |
| DIMENSIONAL FUND ADVISORS LP | 2,809 | 968,484 | 0.0% |
| BlackRock Institutional Trust Company, N.A. | 1,615 | 557,001 | 0.0% |
| BlackRock Investment Management, LLC | 506 | 174,431 | 0.0% |
| DEUTSCHE BANK AG\ | 386 | 292,570 | 0.0% |
| HOLLENCREST SECURITIES LLC | 354 | 122,000 | 0.05% |
| SCHWAB CHARLES INVESTMENT MANAGEMENT INC | 257 | 88,300 | 0.0% |
| LEAVELL INVESTMENT MANAGEMENT, INC. | 236 | 81,271 | 0.04% |
| CREDIT SUISSE AG/ | 210 | 72,421 | 0.0% |
| CARL DOMINO INC | 148 | 51,137 | 0.07% |
| RHUMBLINE ADVISERS | 140 | 48,270 | 0.0% |
| Nationwide Fund Advisors | 134 | 46,116 | 0.0% |
| BLACKROCK ADVISORS LLC | 120 | 41,516 | 0.0% |
| AMERICAN INTERNATIONAL GROUP INC | 114 | 39,384 | 0.0% |
| TFS CAPITAL LLC | 90 | 31,104 | 0.01% |
| ProShare Advisors LLC | 85 | 29,309 | 0.0% |
| Cambridge Investment Research Advisors, Inc. | 73 | 25,000 | 0.0% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 42 | 14,520 | 0.01% |
| RidgeWorth Capital Management LLC | 15 | 5,137 | 0.0% |
| Financial Architects, Inc | 12 | 4,250 | 0.01% |